Itabashi, K, Horiuchi, T, Kusuda, S, et al. Mortality rates for extremely low birth weight infants born in Japan in 2005. Pediatrics. 2009; 123, 445–450.
Singhal, A, Farooqi, IS, O’Rahilly, S, et al. Early nutrition and leptin concentrations in later life. Am J Clin Nutr. 2002; 75, 993–999.
Singhal, A, Fewtrell, M, Cole, TJ, Lucas, A. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet. 2003; 361, 1089–1097.
Ten, S, Maclaren, N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004; 89, 2526–2539.
Baggio, LL, Drucker, DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007; 132, 2131–2157.
Ambati, S, Duan, J, Hartzell, DL, et al. GIP-dependent expression of hypothalamic genes. Physiol Res. 2011; 60, 941–950.
Kawamata, R, Suzuki, Y, Yada, Y, et al. Gut hormones of preterm infants with abdominal symptoms and hypothyroxinemia. Pediatr Int. 2015; 57, 614–619.
Kawamata, R, Suzuki, Y, Yada, Y, et al. Gut hormone profiles in preterm and term infants during the first 2 months of life. J Pediatr Endocrinol Metab. 2014; 27, 717–723.
Itabashi, K, Miura, F, Uehara, R, Nakamura, Y. New Japanese neonatal anthropometric charts for gestational age at birth. Pediatr Int. 2014; 56, 702–708.
Padidela, R, Patterson, M, Sharief, N, Ghatei, M, Hussain, K. Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period. Eur J Endocrinol. 2009; 160, 53–58.
Berseth, CL, Nordyke, CK, Valdes, MG, Furlow, BL, Go, VL. Responses of gastrointestinal peptides and motor activity to milk and water feedings in preterm and term infants. Pediatr Res. 1992; 31, 587–590.
Detel, D, Baticic, L, Varljen, J. The influence of age on intestinal dipeptidyl peptidase IV (DPP IV/CD26), disaccharidases, and alkaline phosphatase enzyme activity in C57BL/6 mice. Exp Aging Res. 2008; 34, 49–62.
Hvidberg, A, Nielsen, MT, Hilsted, J, Orskov, C, Holst, JJ. Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism. 1994; 43, 104–108.
Buteau, J, Foisy, S, Rhodes, CJ, et al. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes. 2001; 50, 2237–2243.
Buteau, J, Foisy, S, Joly, E, Prentki, M. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes. 2003; 52, 124–132.
Farilla, L, Hui, H, Bertolotto, C, et al. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology. 2002; 143, 4397–4408.
Flint, A, Raben, A, Astrup, A, Holst, JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998; 101, 515–520.
Small, CJ, Bloom, SR. Gut hormones and the control of appetite. Trends Endocrinol Metab. 2004; 15, 259–263.
Lucas, A, Boyes, S, Bloom, SR, Aynsley-Green, A. Metabolic and endocrine responses to a milk feed in six-day-old term infants: differences between breast and cow’s milk formula feeding. Acta Paediatr Scand. 1981; 70, 195–200.
Wang, G, Divall, S, Radovick, S, et al. Preterm birth and random plasma insulin levels at birth and in early childhood. JAMA. 2014; 311, 587–596.